Jan O Aasly
Overview
Explore the profile of Jan O Aasly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
4757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gabbert C, Schaake S, Luth T, Much C, Klein C, Aasly J, et al.
BMC Genomics
. 2023 Jun;
24(1):322.
PMID: 37312046
Background: GBA1 variants are the strongest genetic risk factor for Parkinson's disease (PD). However, the pathogenicity of GBA1 variants concerning PD is still not fully understood. Additionally, the frequency of...
2.
Vollstedt E, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, et al.
Mov Disord
. 2023 Jan;
38(2):286-303.
PMID: 36692014
Background: As gene-targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of the estimated...
3.
Birkeland N, Carlsen V, Gulati S, Gustavsson E, Aasly J
Parkinsonism Relat Disord
. 2022 Mar;
96:88-90.
PMID: 35248831
A patient with Parkinson's disease (PD) who was examined as a candidate for DBS was initially rejected due to extensive brain calcifications. Upon second opinion and planning of trajectories she...
4.
Hustad E, Myklebust T, Gulati S, Aasly J
J Mov Disord
. 2021 Jul;
14(3):214-220.
PMID: 34315208
Objective: Few studies have followed Parkinson's disease (PD) patients from the time of diagnosis to the date of death. This study compared mortality in the Trondheim PD cohort to the...
5.
Aasly A, Aasly J
Behav Neurol
. 2021 May;
2021:5559926.
PMID: 34035867
Parkinson's disease (PD) patients may have a specific personality profile, which includes being introvert, cautious and devoted to hard work. The evaluation of psychological characteristics must be evaluated according to...
6.
Aasly J
Front Neurosci
. 2021 Feb;
15:634666.
PMID: 33584195
The first families with LRRK2 related Parkinson's disease (PD) were presented around 15 years ago and numerous papers have described the characteristics of the phenotype. The prevalence of autosomal dominant...
7.
Yilmaz A, Ugur Z, Ustun I, Akyol S, Bahado-Singh R, Maddens M, et al.
Cells
. 2020 Nov;
9(11).
PMID: 33142859
CSF from unique groups of Parkinson's disease (PD) patients was biochemically profiled to identify previously unreported metabolic pathways linked to PD pathogenesis, and novel biochemical biomarkers of the disease were...
8.
Delcambre S, Ghelfi J, Ouzren N, Grandmougin L, Delbrouck C, Seibler P, et al.
Front Neurol
. 2020 Sep;
11:881.
PMID: 32982917
Several mutations in leucine-rich repeat kinase-2 (LRRK2) have been associated with Parkinson's disease (PD). The most common substitution, G2019S, interferes with LRRK2 kinase activity, which is regulated by autophosphorylation. Yet,...
9.
Nybo C, Gustavsson E, Farrer M, Aasly J
Parkinsonism Relat Disord
. 2020 Aug;
78:105-108.
PMID: 32814227
Introduction: Biallelic mutations in PTEN-induced putative kinase 1 (PINK1) is a relatively common cause of autosomal recessive early-onset Parkinson's disease (PD). However, only three PINK1 patients with brain autopsy have...
10.
Aasly J
J Mov Disord
. 2020 Jun;
13(2):81-96.
PMID: 32498494
Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects 1-2% of people by the age of 70 years. Age is the most important risk factor, and most cases are...